The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Rare Lung Diseases — Diagnosis, Treatment, and Follow-Up

Diagnosis, treatment, and long-term follow-up for rare lung diseases.

Multidisciplinary management with advanced imaging, tissue sampling, and long-term follow-up for rare lung diseases such as idiopathic pulmonary fibrosis, sarcoidosis, and lymphangioleiomyomatosis.

Indication

  • Unexplained progressive shortness of breath and dry cough developing over months
  • Ground-glass, honeycomb, or nodular patterns on high-resolution CT
  • Unexplained hypoxia, finger clubbing, or weight loss
  • History of occupational dust exposure, bird-keeping, mold-rich environments, or relevant medications
  • Interstitial lung involvement on a background of rheumatologic disease
  • Recurrent pneumothorax or unexplained cystic lung findings

Preparation

  • Bring previous chest X-rays, CT images, and pulmonary function tests
  • Document occupational and environmental exposures (asbestos, silica, birds, mold)
  • List current medications, especially amiodarone, methotrexate, and biologic therapies
  • Fasting for 6-8 hours before bronchoscopy if planned
  • Adjust blood thinners with physician approval

How it's performed

  1. Detailed history and physical examination to assess symptom course and exposures
  2. High-resolution chest CT and pulmonary function testing including diffusion (DLCO) when needed
  3. Autoimmune markers, angiotensin-converting enzyme, and relevant serologic tests
  4. Bronchoscopy with bronchoalveolar lavage and transbronchial biopsy; cryobiopsy in suitable cases
  5. Confirmation of diagnosis by a multidisciplinary panel (pulmonology, radiology, pathology)
  6. Antifibrotic, immunosuppressive, or targeted therapy planned according to the specific disease

Post-procedure

  • Pulmonary function tests and oxygen saturation checks every 2-3 months in the first 6 months
  • Radiologic monitoring with high-resolution CT 1-2 times per year
  • Pulmonary rehabilitation and long-term oxygen therapy when needed
  • Liver, kidney, and blood tests to monitor medication side effects
  • Pre-evaluation for lung transplantation in advanced cases

Risks

  • Bleeding, pneumothorax, and infection related to bronchoscopic procedures
  • Liver, gastric, and bone marrow side effects from immunosuppressive or antifibrotic therapy
  • Respiratory failure and pulmonary hypertension during disease progression
  • Rapid deterioration and hospitalization risk during exacerbations
  • Increased susceptibility to concurrent infections

FAQ

Are rare lung diseases hereditary?

Some (e.g., familial pulmonary fibrosis, lymphangioleiomyomatosis) may have a genetic basis; however, most arise from environmental, autoimmune, or incompletely understood factors.

Can lung tissue return to normal with treatment?

Current treatments generally slow disease progression and reduce symptoms; reversal of established fibrosis is limited, which is why early diagnosis is important.

Is lung biopsy mandatory?

In some diseases, clinical and radiologic findings may be sufficient for diagnosis; however, when the differential diagnosis is unclear, the multidisciplinary panel may recommend bronchoscopic or surgical biopsy.

Is pulmonary rehabilitation helpful?

Regular pulmonary rehabilitation programs can favorably affect shortness of breath, fatigue, and exercise capacity; they are planned with a physiotherapist according to disease stage.